Canine Hip Dysplasia: From Early Diagnosis to Long-Term Management

Hip dysplasia is one of the most common orthopedic conditions in dogs, affecting millions of dogs across all sizes and breeds. The term sounds severe, but the reality is nuanced: hip dysplasia exists on a spectrum from mild joint laxity with no symptoms to severe arthritis causing significant pain and mobility loss. Many dogs with radiographic hip dysplasia live full, active, comfortable lives with appropriate management. Understanding the condition — and starting early — gives your dog the best chance at exactly that outcome.

What Is Hip Dysplasia?

Canine hip dysplasia (CHD) is an abnormal development of the hip joint in which the femoral head (ball) and acetabulum (socket) don't fit together properly. Instead of a tight, congruent ball-and-socket joint, the fit is loose — a condition called joint laxity or subluxation. This abnormal movement causes microtrauma with every step, leading to cartilage damage, inflammation, and over time, secondary osteoarthritis.

The condition is developmental — it results from abnormal bone growth during the rapid growth phases of puppyhood — but its expression is strongly influenced by both genetics and environment. It is polygenic, meaning many genes contribute, which is why it can appear in dogs from "clear" parents and why breed-wide screening programs require generations of selective breeding to meaningfully reduce prevalence.

Which Dogs Are Affected?

Hip dysplasia is most commonly associated with large and giant breeds: German Shepherds, Labrador Retrievers, Golden Retrievers, Rottweilers, Great Danes, Mastiffs, Saint Bernards, and Bernese Mountain Dogs. However, it also affects medium breeds (Bulldogs, Pugs, Staffordshire Bull Terriers) and is not absent in small breeds.

Prevalence varies dramatically by breed. Orthopedic Foundation for Animals (OFA) data shows that English Bulldogs have over 70% of screened individuals with some degree of hip dysplasia, while sighthound breeds have some of the lowest rates in the canine population. Knowing your breed's baseline risk helps calibrate monitoring and screening decisions.

Environmental factors that influence severity include: rapid growth rate (especially in large breeds fed high-calorie diets), excessive exercise on hard surfaces during puppyhood (before growth plates close), obesity, and possibly dietary calcium/phosphorus imbalances.

Two Phases of Clinical Disease

The juvenile phase (4–12 months): Young dogs with significant joint laxity may show signs of pain and lameness during and after exercise, difficulty rising, bunny-hopping gait (using both hind limbs together rather than alternating), reluctance to climb stairs, and muscle atrophy of the hindquarters. This phase can be quite painful because of joint inflammation and instability, even before significant arthritis has developed.

The mature arthritic phase (typically 1–2+ years): As the body attempts to stabilize the unstable joint, it lays down new bone (osteophytes) around the joint margins. This remodeling provides some stability but comes at the cost of progressive arthritis. Signs include stiffness (especially after rest), decreased activity, hindlimb muscle wasting, difficulty rising, and reduced ability to climb, jump, or exercise for extended periods. Progression is often gradual and owners sometimes attribute it to "just getting older" — which delays intervention.

Diagnosis: Radiography Is the Standard

Physical examination findings that suggest hip dysplasia include pain on hip extension, decreased range of motion, crepitus (grinding sensation during joint movement), muscle atrophy, and a positive Ortolani sign (a palpable "clunk" as a subluxated femoral head reduces back into the acetabulum — requires sedation to perform reliably).

Definitive diagnosis requires radiographs. Standard OFA hip radiographs are taken with the dog positioned on their back with the hind legs extended and parallel — a position that requires sedation or anesthesia in most dogs to achieve correct positioning and muscle relaxation. The radiographs are evaluated for femoral head shape, acetabular depth, joint space, and the presence of arthritis.

PennHIP (University of Pennsylvania Hip Improvement Program) is a specialized technique using distraction radiographs to directly measure joint laxity — expressed as a distraction index (DI). PennHIP can be performed as early as 16 weeks of age and is considered more sensitive than standard OFA views for identifying dogs likely to develop osteoarthritis. It requires certification of the veterinarian performing the technique.

Surgical Options

Several surgical procedures are available, and the right choice depends heavily on the patient's age, severity of dysplasia, degree of arthritis already present, and owner circumstances:

Juvenile Pubic Symphysiodesis (JPS): Performed in puppies under 20 weeks of age. The pubic symphysis (cartilage joining the two pelvic bones) is fused with electrocautery, which redirects subsequent pelvic growth to rotate the acetabulum over the femoral head, improving coverage. Very effective when done early enough — this is why early screening matters.

Triple Pelvic Osteotomy (TPO) / Double Pelvic Osteotomy (DPO): For dogs with significant dysplasia but minimal arthritis, typically 5–12 months. The pelvis is cut in two or three places and the acetabulum is rotated to improve coverage of the femoral head. Highly effective when performed at the right stage and by an experienced orthopedic surgeon.

Femoral Head and Neck Excision (FHO): Removal of the femoral head, allowing a fibrous false joint to form. Significantly less expensive than total hip replacement. Outcomes are generally better in small to medium dogs and cats than in large dogs. Pain relief is reliably achieved; function varies.

Total Hip Replacement (THR): The most effective surgical treatment for end-stage hip dysplasia in large dogs. A prosthetic metal ball and polyethylene cup replace the diseased joint. In experienced hands, outcomes are excellent with high-quality pain relief and normal function restored in most patients. Requires board-certified veterinary orthopedic surgeon; significant upfront cost.

Medical and Rehabilitation Management

Not all dysplastic dogs require or are candidates for surgery. Medical management can provide excellent quality of life, particularly in mild-moderate cases or when surgery is declined.

Weight management: The single most impactful intervention for any dog with joint disease. Every pound of excess weight multiplies joint loading forces. Achieving and maintaining lean body condition dramatically reduces pain and slows arthritis progression.

NSAIDs: Carprofen, meloxicam, grapiprant, and deracoxib are the primary medications for pain management. Regular bloodwork monitoring is essential for long-term NSAID use to screen for GI and kidney effects.

Joint supplements: Glucosamine and chondroitin sulfate have some supportive evidence; omega-3 fatty acids (EPA/DHA) have stronger evidence for anti-inflammatory effects on cartilage. These are appropriate additions to a comprehensive pain management plan.

Physical rehabilitation: Structured hydrotherapy (underwater treadmill), massage, range-of-motion exercises, and therapeutic laser significantly improve muscle mass, joint mobility, and pain levels. Veterinary rehabilitation practitioners (CCRP or CCRT certified) can design individualized programs.

Newer modalities: Librela (bedinvetmab), a monthly injectable monoclonal antibody targeting nerve growth factor (NGF), was approved for canine osteoarthritis pain in 2023 and represents a significant addition to pain management options, particularly for dogs with GI sensitivity to NSAIDs.

Hip dysplasia is not a terminal diagnosis. With early identification, appropriate intervention (surgical or medical), weight control, and consistent management, the vast majority of affected dogs live happy, active, pain-controlled lives with their families.